These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31337967)

  • 1. Huaier polysaccharide inhibits the stem-like characteristics of ERα-36
    Hu B; Yan W; Wang M; Cui X; Hu Y; Chen Q; Zhang Y; Qi X; Jiang J
    Int J Biol Sci; 2019; 15(7):1358-1367. PubMed ID: 31337967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
    Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
    Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer.
    Li W; Yang H; Li X; Han L; Xu N; Shi A
    Oncol Rep; 2019 Jan; 41(1):437-446. PubMed ID: 30365081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells.
    Al-Howail HA; Hakami HA; Al-Otaibi B; Al-Mazrou A; Daghestani MH; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
    BMC Cancer; 2016 Jul; 16():540. PubMed ID: 27465411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
    Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
    Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2
    Ly S; Anand V; El-Dana F; Nguyen K; Cai Y; Cai S; Piwnica-Worms H; Tripathy D; Sahin AA; Andreeff M; Battula VL
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33722905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition.
    Sulaiman A; Sulaiman B; Khouri L; McGarry S; Nessim C; Arnaout A; Li X; Addison C; Dimitroulakos J; Wang L
    FEBS Lett; 2016 Dec; 590(24):4606-4616. PubMed ID: 27859250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huaier aqueous extract suppresses human breast cancer cell proliferation through inhibition of estrogen receptor α signaling.
    Wang X; Zhang N; Huo Q; Sun M; Lv S; Yang Q
    Int J Oncol; 2013 Jul; 43(1):321-8. PubMed ID: 23686317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.
    Lü J; Zhao Q; Guo Y; Li D; Xie H; Liu C; Hu X; Liu S; Hou Z; Wei X; Zheng D; Pestell RG; Yu Z
    J Exp Clin Cancer Res; 2023 Apr; 42(1):93. PubMed ID: 37081505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Huaier on Melanoma Invasion, Metastasis, and Angiogenesis.
    Su D; Jiang B; Yang Y; Miao Y; Fu Q; Zhang F
    Biomed Res Int; 2020; 2020():8163839. PubMed ID: 32596377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).
    Ma F; Li H; Wang H; Shi X; Fan Y; Ding X; Lin C; Zhan Q; Qian H; Xu B
    Cancer Lett; 2014 Oct; 353(2):153-9. PubMed ID: 25130168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
    Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
    [No Abstract]   [Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells.
    Chen X; Ma N; Zhou Z; Wang Z; Hu Q; Luo J; Mei X; Yang Z; Zhang L; Wang X; Feng Y; Yu X; Ma J; Guo X
    Med Sci Monit; 2017 Jun; 23():2674-2683. PubMed ID: 28570501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.
    Yu Y; Yin W; Yu ZH; Zhou YJ; Chi JR; Ge J; Cao XC
    J Exp Clin Cancer Res; 2019 Jan; 38(1):22. PubMed ID: 30658681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
    Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
    Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
    Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.